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Objective: Our objective was to compare protein profiles of cerebrospinal fluid between control animals and
those subjected to cardiopulmonary bypass after moderate versus deep hypothermic circulatory arrest with selec-
tive cerebral perfusion.
Methods: Immature Yorkshire piglets were assigned to one of four study groups: (1) deep hypothermic circula-
tory arrest at 18C, (2) deep hypothermic circulatory arrest at 18Cwith selective cerebral perfusion, (3) moderate
hypothermic circulatory arrest at 25Cwith selective cerebral perfusion, or (4) age-matched control animals with-
out surgery. Animals undergoing cardiopulmonary bypass were cooled to their assigned group temperature and
exposed to 1 hour of hypothermic circulatory arrest. After arrest, animals were rewarmed, weaned off bypass, and
allowed to recover for 4 hours. Cerebrospinal fluid collected from surgical animals after the recovery period was
compared with cerebrospinal fluid from controls by surface-enhanced laser desorption/ionization time-of-flight
mass spectrometry. Protein spectra were analyzed for differences between groups by Mann–Whitney U test
and false discovery rate analysis.
Results: Baseline and postbypass physiologic parameters were similar in all surgical groups. A total of 194 pro-
tein peaks were detected. Compared with controls, groups 1, 2, and 3 had 64, 100, and 13 peaks that were sig-
nificantly different, respectively (P < .05). Three of these peaks were present in all three groups.
Cerebrospinal fluid protein profiles in animals undergoing cardiopulmonary bypass with moderate hypothermic
circulatory arrest (group 3) were more similar to controls than either of the groups subjected to deep hypothermia.
Conclusions: The mass spectra of cerebrospinal fluid proteins are altered in piglets exposed to cardiopulmo-
nary bypass and hypothermic circulatory arrest. Moderate hypothermic circulatory arresst (25C) with selec-
tive cerebral perfusion compared with deep hypothermic circulatory arrest (18C) is associated with fewer
changes in cerebrospinal fluid proteins, when compared with nonbypass controls. (J Thorac Cardiovasc
Surg 2009;138:1290-6)
Congenital Heart Disease Allibhai et alDeep hypothermic circulatory arrest (HCA)with andwithout
selective cerebral perfusion (SCP) continues to be commonly
used for repair of complex congenital heart disease (CCHD)
in infants, particularly for operations involving aortic arch re-
construction. Even though deep HCA is known to be neuro-
protective, a significant portion of children undergoing such
operations continue to have neurologic sequelae.1,2 It has
been increasingly recognized that the etiology of cerebral in-
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lated to perioperative management.2 However, perioperative
factors, such as HCA, are the most amenable to modification
and therefore have remained as significant targets for inter-
vention in efforts to improve outcomes in children with
CCHD. Intuitively, prolonged exposure to circulatory arrest
without cerebral perfusion even with hypothermic protection
places children at risk for both overt and subtle neurologic in-
jury. This has led to a number of investigative efforts into
methods to modify the use of deep HCA, including the use
of SCP and moderate temperature HCA.1-4
Low-flow antegrade SCP during deep HCA has been
commonly used with the belief that by maintenance of unin-
terrupted cerebral perfusion, brain energy metabolism and
oxygenation will be better preserved, thereby limiting cellu-
lar hypoxic–ischemic damage.5 A number of different surgi-
cal techniques to use SCP have been described in the
literature, and it is unclear which strategy is optimal or
whether SCP is beneficial at all.6-10 More recently, several
authors have advocated using moderate temperaturesrgery c December 2009




CCHD ¼ complex congenital heart disease
CPB ¼ cardiopulmonary bypass
CSF ¼ cerebrospinal fluid
FDR ¼ false discovery rate
HCA ¼ hypothermic circulatory arrest
SCP ¼ selective cerebral perfusion
SELDI–TOF ¼ surface-enhanced laser
desorption/ionization time-of-flight
(22C–30C) for HCA with SCP, advocating that shorter
cardiopulmonary bypass (CPB) times result in less systemic
inflammation and capillary leak, leading to less injury and
quicker recovery with presumably similar neuroprotec-
tion.7,11 Preliminary studies using a strategy of moderate
HCA with SCP have been encouraging; however, the bene-
fits and safety of this strategy, to include long-term out-
comes, still need to be demonstrated.7,12,13
In this study, we analyzed protein profiles of cerebrospinal
fluid (CSF) collected from piglets after CPB under moderate
versus deep HCA with and without SCP and compared them
with control CSF. We theorized that CSF protein changes
likely would reflect alterations in underlying brain pathophys-
iology and perhaps lead to the identification of biomarkers
of interest. We used surface-enhanced laser desorption/
ionization time-of-flight (SELDI–TOF) mass spectrometry
to analyze the CSF protein profiles. SELDI–TOF mass spec-
trometry has been used to analyze proteins from a variety of
samples such as serum, CSF, urine, amniotic fluid, and cord
blood and has facilitated the detection of biomarkers for can-
cer, Alzheimer disease, intra-amniotic infection, retinopathy
of prematurity, and various other disease states.14-18 The liter-
ature regarding the utility of proteomic analysis of CSF to date
has mostly focused on the idea that normal CSF has a limited
number of proteins; therefore, an increased heterogeneity in
proteomic profiles is most often representative of underlying
central nervous system pathophysiology that occurs in certain
disease states. Because CSF is produced and in direct contact
with the central nervous system, its analysis via proteomics is
well suited for biomarker discoverywhen attempting to differ-
entiate healthy versus injured brain tissue.19,20
Of interest, SELDI–TOF mass spectrometry technology
has been previously used in an animal CPB model to define
proteomic changes in the serum and cerebral cortex tissue of
neonatal piglets after deep HCA21; however, no studies to
date have attempted to define how varied temperature condi-
tions and antegrade SCP might alter cerebral protein profiles
after recovery from CPB. We hypothesized that CSF protein
profiles from piglets undergoing HCA with SCP at either
18C or 25C, compared with HCA alone at 18C, would
be more similar to CSF from non-CPB controls, suggestingThe Journal of Thoracic and Cless underlying cerebral injury in these experimental groups.
We also sought to determine whether there was a differing
degree of protein change in CSF when SCP was performed
at 25C compared with 18C.
METHODS
All procedures were carried out according to a protocol approved by the
Wilford Hall Medical Center Institutional Animal Care and Use Committee.
All animals were maintained in an American Association for Accreditation
Laboratory Animal–accredited facility and received care in compliance with
the ‘‘Guide for the Care and Use of Laboratory Animals’’ prepared by the
National Academy of Sciences and published by the National Institutes of
Health.
Experimental Design
Twenty-nine juvenile piglets (4–5 weeks of age, weight 8–10 kg) were
anesthetized, intubated, placed on mechanical ventilation, and randomized
to either control or CPB. CPB animals were assigned to one of three HCA
experimental groups: group 1 (n ¼ 7), deep HCA at 18C without SCP;
group 2 (n¼ 7), deepHCA at 18Cwith SCP; and group 3 (n¼ 7), moderate
HCAat 25Cwith SCP.All CPB animals underwent circulatory arrest for 60
minutes after cooling to their target temperature. After HCA, animals were
rewarmed, weaned from CPB, and then allowed to recover for 4 hours.
Animals assigned to the control group (n¼ 8) did not undergo any additional
treatment or surgery after their initial instrumentation. CSF was collected
from all animals via lumbar puncture at the end of the study period before
necropsy. After recovery off CPB, all animals were electively killed via
deep sedation followed by a right atrial incision resulting in exsanguination.
Surgical and CPB Protocol
Anesthesia and paralysis were provided throughout the study period with
inhaled isoflurane, intravenous fentanyl, and pancuronium. Both the femo-
ral artery and vein were cannulated for measurement of pressure and for
infusion of fluids and drugs. A transabdominal Foley bladder catheter
(8F–10F) was inserted surgically for measurement of urine output, and tem-
perature probes were placed in the rectum and nasopharnx. After median
sternotomy, the ascending aorta and right atrium were cannulated. A left
atrial vent was placed for left ventricular decompression. After systemic
heparinization (400 IU/kg), nonpulsatile CPB was instituted at a flow rate
of 100 mL $ kg1 $min1. The CPB circuit consisted of a roller pump, mem-
brane oxygenator (Minimax; Medtronic Bio-Medicus, Minneapolis, Minn),
and sterile 1ˇ/4 -inch tubing. The circuit was primed with blood previously
harvested from a donor pig mixed with crystalloid prime solution (Normo-
sol; Abbott Labs, Chicago, Ill) to maintain the hematocrit value at greater
than 25% to 30%.
Once on CPB, animals were cooled to their target temperature at the
same rate according to their assigned study group (18C for groups 1 and
2 and 25C for group 3). Before HCA, electromechanical myocardial arrest
was instituted by clamping of the aorta and instillation of cold cardioplegic
solution into the aortic root blood. Animals assigned to groups 2 and 3 were
given SCP at 10 mL $ kg1 $min1 by advancing the aortic cannula into the
innominate artery at the beginning of HCA,22 and the innominate artery was
snared around the cannula to provide SCP. The other arch vessel was snared
to mimic the clinical situation of a bloodless field and avoid any steal from
cerebral circulation via the vertebral and other cranial vessels. In pigs, unlike
humans, both carotid arteries arise from the first arch vessel. After the com-
pletion of HCA, all snares were removed, the aortic cannula was directed
back into the aortic arch, and full CPB was re-established. Cerebral oxygen
saturations were continuously monitored throughout the study protocol by
near-infrared spectroscopy (Somanetics, Troy, Mich).
During CPB, perfusion parameters that were monitored included flow
rate (L/min), mean arterial pressure, temperature (nasopharyngeal, rectal,ardiovascular Surgery c Volume 138, Number 6 1291
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Dand venous), inspired oxygen fraction and sweep gas flow rate, CDI 500
(pH, PCO2, PO2, base, potassium, hematocrit, and venous oxygen saturation),
electrolytes, arterial blood gases, and activated clotting times. CPB flowwas
adjusted to maintain pH between 7.3 and 7.5 using pH-stat blood gas man-
agement. At completion of 60minutes of HCA, all groups were rewarmed to
36C and weaned from CPB. All surgical animals underwent modified
ultrafiltration for a total of 500 mL, typically raising the hematocrit value
to 35%. After modified ultrafiltration, the animals were decannulated and
allowed to recover for 4 hours after CPB.
Sample Collection and Preparation
Several milliliters of CSF were collected by lumbar puncture at the end
of the 4-hour recovery period, just before the animals were humanely
killed. CSF samples were immediately placed on ice and then stored at
80C for later analysis. Using 10 mL of each CSF and corresponding se-
rum sample, we performed the Pierce BCA Protein Assay (catalog No.
23225; Fisher Scientific, Hampton, NH), which combines the reaction of
protein (albumin) with copper in an alkaline medium with bicinchoninic
acid. The samples were evaluated with a BioTek Synergy HT microplate
reader (BioTek Instruments, Inc, Winooski, Vt). Differences between
groups were compared by 1- way analysis of variance (Sigma Stat, version
3.5, Richmond Calif).
SELDI–TOF Mass Spectrometry
All CSF samples were processed simultaneously, and each sample was
examined in duplicate. CSF (20 mL) was initially denatured with 30 mL of
9 mol/L urea/2% 3[3-cholaminopropyl diethylammonio]-1-propane sulfo-
nate/50mmol/L tris-(hydroxymethyl)-aminomethane (pH 9). Using a pipet-
ting robot (Biomek2000; BeckmanCoulter Inc, Fullerton, Calif), we applied
an aliquot (10mL) of the denaturedCSF to each spot of a SELDI ProteinChip
array (Bio-Rad, Hercules, Calif) in 90 mL of the appropriate binding buffer.
Samples were bound to CM10 ProteinChips, a weak cation exchanger that
binds proteins with net positive charge, in 0.1 mol/L sodium acetate buffer
at pH 4. After binding for 30 minutes, the ProteinChips were washed three
times with 0.1 mol/L sodium acetate buffer at pH 4, followed by two brief
washes with water, and allowed to dry. The energy-absorbing matrix mole-
cule sinapinic acid (SigmaChemical Co, St Louis,Mo)was added to the sur-
face of one set of chips (two applications of 1 mL of a 50% saturated solution
in 50% acetonitrile/0.5% trifluoroacetic acid). targeting higher molecular
weight proteins, and the energy absorbing molecule a-cyano-4-hydroxycin-
namic acid (Sigma Chemical Co) targeting lower molecular weight proteins
was added to the surface of another set of chips (two applications of 1 mL of
a 25% saturated solution in 50% acetonitrile/0.5% trifluoroacetic acid).
Mass spectra of proteins that bound to the protein chip surface were gener-
ated for each CSF sample using a Bio-Rad PCS 4000 Enterprise Edition
mass spectrometer, with a total of 6 spectra generated for each sample (using
three laser energies [1400 nJ for a-cyano-4-hydroxycinnamic acid, 3800 nJ
and 7250 nJ for sinapinic acid], run in duplicate). Spectra were externally
calibrated using spectra of a mixture of protein standards in the range of
7 to 30 kD.
Bioinformatics
Spectra were processed and analyzed by ProteinChip Data Manager
Software 3.0.7 Enterprise Edition (Bio-Rad), a program that identifies,
quantifies, and processes protein peak information from SELDI–TOF
mass spectra. The Mann–Whitney U test was used to discover peaks dis-
criminating between the control and surgical study groups. To control for
‘‘multiple hypothesis testing,’’ we used a permutation-based approach for
the false discovery rate (FDR) estimation.23,24When a givenP-value thresh-
old was applied to the original data set to evaluate the significance of all
peaks, the total number of differential peaks consisting of true and false pos-
itives was obtained. The same P-value threshold, when applied to all 1001292 The Journal of Thoracic and Cardiovascular Spermutated data sets, yielded 100 different numbers of positive differential
peaks. The ratios between the false positives, including the mean, median,
and 95% distribution of the 100 different false positives and total number
of positives, was used for the estimation of the FDR. After a global assess-
ment of FDR, the local FDR was computed and used as an additional guide-
line for choosing the optimized P-value threshold and deciding whether
a peak was truly differentially expressed.25,26
RESULTS
In 2 surgical animals in each group, either CSF could not
be successfully obtained or the animals did not survive until
the end of the 4-hour recovery period. This left a total of
23 CSF samples available for analysis, 5 from each surgical
group and 8 from control animals.
CPB Physiologic Parameters
Table 1 shows baseline physiologic measurements of all
surgical animals on CPB before the induction of HCA.
There were no significant differences among any of the
groups. Group 1 and 2 animals, cooled to 18C, were
exposed to a significantly longer total CPB time than were
group 3 animals, which were only cooled to 25C (156 
10 and 163  6 minutes vs 114  8 minutes, respectively;
P< .02). During the recovery period after CPB, parameters
from all the groups remained similar without significant dif-
ferences noted (data not shown).
CSF Protein Content
Figure 1 shows the distribution of CSF/serum protein
ratios collected at the end of the experiment in all animals.
Of note, group 2 had significantly higher CSF/serum protein
ratios than did both control and group 3 (25)C animals
(P< .01 and P< .05, respectively).
Analysis of Protein Spectra
Figure 2 shows the averaged spectra for the control group
obtained using the three acquisition modes of the mass spec-
trometer, optimized for small, medium, and large proteins.27
A total of 194 protein peaks were detected using the criterion
TABLE 1. Baseline physiologic parameters of surgical animals
Group 1 Group 2 Group 3
CNS temp (oC) 34.7  0.8 35.2  1.1 35.5  1.3
MAP (mm Hg) 53.5  10.7 50.4  10.3 48.0  4.0
ICP (mm Hg) 12.6  3.1 10.5  2.1 10.6  2.5
Hct (%) 28.3  3.4 26.8  2.0 26.0  2.3
Arterial pH 7.45  .08 7.44  .09 7.47  .04
PaO2 (mmHg) 239  80 200  53 219  37
PCO2 (mmHg) 38.4  4.2 40.0  5.6 42.3  5.4
Lactate (mmol/L) 1.1  0.5 0.8  0.2 1.2  0.4
Group 1¼ 18C hypothermic circulatory arrest (HCA) without selective cerebral per-
fusion (SCP); group 2 ¼ 18C HCA with SCP; and group 3 ¼ 25C HCA with SCP.
CNS, Central nervous system;MAP,mean arterial pressure; ICP, intracranial pressure;
Hct, hematocrit; PaO2, arterial oxygen tension; PCO2, carbon dioxide tension.urgery c December 2009
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that peak cluster to be analyzed. Tables of extracted peak
information27 were analyzed by the Mann–Whitney U test.
Table 2 shows the number of significantly different peaks
detected between groups, using a threshold of P<.05. Com-
pared with controls, group 1 had 64 peaks that were signif-
icantly different. Group 2 had 100 peaks that were
significantly different from controls, and group 3 had 13
peaks that were significantly different, suggesting that group
2 was most different from controls and group 3 most similar.
Using c2 contingency table analysis, we found group 2 to be
significantly more different from controls than group
3 (c2 ¼ 92; P< .0001) and also more different than group
1 (c2 ¼ 12; P< .0003). Analysis of CSF protein profiles
showed that when comparing groups 1 and 2 (deep HCA
at 18C with and without SCP), there were 4 protein peaks
that were significantly different in intensity, as seen in Table
2. When comparing groups 2 and 3 (deep [18C] vs moder-
ate [25C] HCA with SCP), there were 23 protein peaks that
were significantly different in intensity.
FIGURE 1. CSF/serum protein ratio (n ¼ 5/group). Data are presented as
a box plot showing median line and 25th and 75th percentiles, respectively.
Group 1 ¼ 18C HCA without SCP; group 2 ¼ 18C HCA with SCP; and
group 3¼ 25CHCAwith SCP. A, P<.01 versus control; b, P<.05 versus
18C SCP. CSF, Cerebrospinal fluid; HCA, hypothermic circulatory arrest;
SCP, selective cerebral perfusion.The Journal of Thoracic and CFigure 3 shows a Venn diagram representing the relation-
ship between the significantly different peaks from each of
the three surgical groups compared with controls. There
were 50 peaks that were common for groups 1 and 2, deep
HCA at 18C with and without SCP. There were 4 peaks
that were common for groups 2 and 3 (HCA with SCP at
18C and 25C). There were 3 peaks that were common in
all three groups. These peaks had m/z of 28,720, 4,568,
and 4,775. In all three groups, the 28,720 peak was increased
relative to control. Likewise in all three groups, the 4,568
peak and the 4,775 peak were decreased relative to control.
FDR
For group 1, HCA without SCP at 18C, median FDR
crosses the threshold of 5% at 64 peaks with P< .05. For
group 2, HCA plus SCP at 18C, the median FDR crosses
the threshold of 5% at 100 discoveries at P< .05. In con-
trast, there are no peaks that have an FDR less than 5%
when controls are compared with HCA with SCP at 25C,
despite there being 13 peaks with P<.05. Therefore, the dif-
ferences seen when both groups at 18Cwere compared with
controls likely represent true differences based on global
FDR analysis, whereas many if not all the apparently signif-
icant peaks when controls are compared to HCA plus SCP at
25C may be due to chance. Overall, the CSF of the group 3
animals is most similar to that of controls, and several of the
peaks in this group that approach statistical significance are
the same peaks found to be statistically different in the other
two groups.
The local FDR was also determined for the three potential
biomarker peaks that were significantly different when com-
paring controls with each of the three groups. As seen in
Table 3, both groups 1 and 2 had local FDR of less than
10% for the potential biomarker peaks when compared
with controls. For each of the group 3 peaks, however, the
local FDR was greater than 10% when compared with con-
trols, suggesting that these peaks do not represent true differ-
ences compared with control. When the results with all three
experimental groups were compared with controls, the local
FDR for each of the three potential biomarker peaks was
0.6%, suggesting that when all three experimental groupsFIGURE 2. Averaged spectra for the control group obtained using the three acquisition modes of the mass spectrometer, optimized for small, medium, and
large proteinsardiovascular Surgery c Volume 138, Number 6 1293
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compared with control for these potential biomarkers.
DISCUSSION
In this study, we were able to successfully characterize
CSF protein profiles using SELDI–TOF mass spectrometry
for piglets undergoing HCA at 25C and 18C with and
without SCP. We have shown that CPB with HCA in all
of our study groups results in significant changes in CSF
protein expression when compared with healthy nonsurgical
control animals. Of interest, we found that CPB piglets from
group 2 that underwent deep HCA at 18Cwith SCP had the
most profound changes in their CSF protein profiles when
compared with controls. Additionally, group 3 piglets that
underwent moderate HCA at 25C had the least number of
changes in protein peaks when compared with controls.
In a recent novel study, Sheikh and associates21 used pro-
teomics to characterize cerebral injury in a CPB animal
model. Plasma and brain tissue samples from piglets that
underwent CPB with deep HCA at 18C without SCP
were analyzed using a combination of 2-dimensional elec-
trophoresis and mass spectrometry and compared with those
from control piglets that underwent a sham operation. The
authors correlated their proteomic findings to brain histology
and found that deep HCA was associated with differential
expression of 6 identifiable proteins, one of which they
thought could be a potential biomarker. In our study, we
compared CPB with deep HCA and SCP at 18C and mod-
erate HCA and SCP at 25C with control animals and
showed that changes in the differential expression of pro-
teins can also be seen in the CSF. We found that moderate
HCA with SCP resulted in the least amount of change in
CSF protein pattern compared with control animals. When
the protein patterns in all of the surgical animals were com-
pared, we found a total of three proteins that were signifi-
cantly different in CPB animals versus controls, any or all
of which could serve as a biomarker on further identification.
Inasmuch as control animals were not subjected to surgery,
the changes seen may be due to a combination of surgery and
CPB. Nevertheless, a distinct difference in the magnitude of
various protein peaks was noted among the animals treated
with the three different experimental conditions when com-
pared with control animals.
Different from Sheikh and associates,21 our study used
SELDI–TOF methods. Ours is the only study that we
TABLE 2. Number of different protein peaks between groups (P<.05)
Control Group 1 Group 2
Group 1 64
Group 2 100 4
Group 3 13 * 23
Group 1¼ 18C hypothermic circulatory arrest (HCA) without selective cerebral per-
fusion (SCP); group 2 ¼ 18C HCA with SCP; and group 3 ¼ 25C HCA with SCP.
*Not relevant comparison.1294 The Journal of Thoracic and Cardiovascular Sknow of that has used this emerging proteomic technology
in a CPB animal model. SELDI–TOF offers great potential
for the identification and quantification of proteins in body
fluids, but there are challenges in translating its findings
into meaningful results that can be applied to clinical prac-
tice. Barriers that have been cited include the complexity
of the proteome in biological samples, the presence of
high abundance proteins that may interfere with detection
of low abundance proteins, and the high rate of false posi-
tives associated with high throughput data.28 Analysis of
protein profiles has been used to look for differences
between disease states and controls, but this strategy has
been criticized for its inconsistent data processing that can
greatly alter the resulting mass spectra and thus the protein
profiles.29 Differences in data preparation after acquisition
of spectra, along with inaccuracies in sample preparation
and mass calibration, may also alter results.
To minimize this type of error, we handled all samples in
our protocol the same and processed using robotic technol-
ogy after mass calibration before performing the experiment.
Recent SELDI–TOF studies using these more stringent
guidelines for sample and data set preparation have shown
FIGURE 3. Venn diagram representing the relationship between the sig-
nificantly different peaks from each of the three surgical groups compared
with controls. Group 1 ¼ 18C HCA (hypothermic circulatory arrest) with-
out SCP (selective cerebral perfusion); group 2¼ 18CHCAwith SCP; and
group 3 ¼ 25C HCA with SCP.
TABLE 3. Local false discovery rates for potential biomarker peaks in
surgical groups compared with controls
Peak (m/z) Group 1 Group 2 Group 3 All surgical groups
4,568 0.055 0.011 0.490 0.006
4,775 0.048 0.011 0.490 0.006
28,720 0.048 0.095 0.680 0.006
Group 1¼ 18C hypothermic circulatory arrest (HCA) without selective cerebral per-
fusion (SCP); group 2 ¼ 18C HCA with SCP; and group 3 ¼ 25C HCA with SCP.urgery c December 2009
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ity in detection of proteins, but with this increase in sensitiv-
ity, there is an inherent risk in over-analysis of the data.
Differences in profiles may be more likely to be found by
chance and do not always represent a true difference in the
populations. Our statistical analysis takes this into account,
and FDR calculations were performed and reported.
Although data from research studies and anecdotal clini-
cal reports have been promising, the use of SCP has not
yet translated into proven efficacy in children when com-
pared with deep HCA alone. Only one randomized trial
has been published to date looking at the impact of SCP
with HCA at 18C compared with HCA without SCP at
18C on neurodevelopmental outcome in children after the
Norwood operation, and it failed to detect a difference at
12 months of age.6 As previously noted, the utility of SCP
has been complicated by significant variability of other
CPB parameters manipulated in the operating room, includ-
ing blood gas perfusion strategy (alpha-stat vs pH-stat),
hemodilution, and temperature, all of which alter cerebral
blood flow and oxygenation.2-4 Although in theory SCP
should be of benefit to the brain, there is real potential for in-
creased oxidative stress, inflammation, and excess cerebral
perfusion pressure resulting from SCP flow exacerbating
rather than attenuating neurologic injury, and this may be
temperature dependent.
In addition, even though some centers have begun per-
forming aortic arch operations at 25C or warmer, the use
of SCP during HCA at more moderate temperatures such
as 25C compared with traditional deep HCA should be
approached with caution, because the safety and utility of
the strategy remains unproven.7,12,13 Of particular interest
in our analysis, we did find that group 3 animals (moderate
HCA at 25C) had the least amount of change in the pattern
of CSF protein spectra comparedwith controls. Although the
exact significance of these findings will remain unknown un-
til further analysis can be performed, we can speculate that
perhaps this lack of difference from control in the CSF pro-
tein pattern is reflective of less cerebral injury and inflamma-
tion. Alternatively, this may instead reflect less upregulation
of neuroprotective proteins. The most significant differences
in peaks compared with controls were found in animals
undergoing HCA at 18C. We can speculate that perhaps
the shorter duration in exposure time to CPB in the 25C
animals attenuated injury to the blood–brain barrier, there-
fore resulting in less heterogeneity in CSF protein profiles.
This idea is also supported by the higher CSF/serum protein
levels found in the 18C study groups. It is also of interest and
some concern that the greatest differences were observed in
the 18C with SCP group. This finding warrants further
study, especially if increased changes in CSF proteins truly
correlate with increased underlying brain disease.
In addition to disruption of the underlying blood–brain
barrier, other potential mechanisms that may have resultedThe Journal of Thoracic and Cin the differences observed in CSF protein profiles include
alterations in cellular signaling pathways leading to the
increased production, or perhaps decreased metabolism, of
proteins involved in the inflammatory, oxidative stress,
and other cascades that occur in brain tissue after exposure
to hypoxic–ischemic and reperfusion injury. The increased
concentrations of these proteins could also be the result of
altered cellular update, transport and secretion of various
pathologic proteins, or perhaps represent direct injury to
those cells comprising the blood–brain barrier itself, result-
ing in the direct secretion and/or release of pathologic pro-
teins into the CSF.20,21 Future investigation focused on
identification of potential biomarkers, to include correlation
of proteomic data with brain tissue histology, will ideally
offer more insight into differences that may exist between
the different surgical methods in our study groups.
SELDI–TOF mass spectrometry has facilitated the detec-
tion of biomarkers for numerous disease states.14-30 The
identification of novel biomarkers, particularly serum bio-
markers, predictive of neurologic injury in the CPB and
SCP model can be beneficial in providing clues to the
many unanswered questions that remain surrounding what
constitutes optimal surgical conditions to limit neurologic
injury in children with CCHD.
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